Skip to content
Apex Nursing

Chart — Fundamentals

Pressure Injury Staging Comparison

Side-by-side NPIAP staging comparison — all six pressure injury categories with skin findings, tissue involvement, and nursing considerations for NCLEX and clinical practice.

Educational use only. Pressure injury staging requires in-person clinical assessment. Wounds are never back-staged. This chart is for nursing education and NCLEX preparation. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.

NCLEX Tip: Stage 3 = subcutaneous fat visible, no bone/tendon/muscle. Stage 4 = bone, tendon, or muscle exposed. Wounds never back-stage as they heal. Stable heel eschar is NOT debrided.

All Stages — Comparison

Stage 1

Non-Blanchable Erythema

Skin Findings

Intact skin with non-blanchable localized redness; may appear violet or maroon in dark skin tones; area may feel warmer, cooler, firmer, or softer than surrounding skin

Tissue Involvement

Skin intact — epidermis only affected; no open wound; microvascular changes indicate impaired perfusion

Nursing Considerations

Act immediately — this is the warning sign. Increase repositioning frequency. Apply protective foam dressing to affected area. Assess Braden score and implement full prevention protocol.

NCLEX: Blanchability test: press 3 seconds — non-blanchable = Stage 1. This is the earliest visible stage.

Stage 2

Partial Thickness Skin Loss

Skin Findings

Shallow open ulcer with pink or red, moist wound bed; OR intact or ruptured serum-filled blister; no slough or bruising (bruising suggests DTI)

Tissue Involvement

Partial thickness dermis loss — epidermis and upper dermis destroyed; subcutaneous fat not visible; wound bed is viable (pink/red)

Nursing Considerations

Moisture-retentive dressing (hydrocolloid, thin foam) to maintain moist wound environment. Relieve pressure. Manage moisture. Pain management — Stage 2 is often very painful due to exposed nerve endings.

NCLEX: No slough or bruising in true Stage 2. Blister: do not rupture unless at risk of infection. Very painful — assess and manage pain.

Stage 3

Full Thickness Skin Loss

Skin Findings

Full thickness tissue loss; wound crater; subcutaneous fat may be visible; slough or eschar may be present but does not obscure depth; undermining and tunneling may be present

Tissue Involvement

Epidermis, dermis, and subcutaneous fat involved; bone, tendon, and muscle are NOT visible or directly palpable

Nursing Considerations

Assess and document wound dimensions (L×W×D), undermining, and tunneling. Moist wound healing approach. Consult wound care specialist. Nutritional support — protein and calories critical. Debridement per order if necrotic tissue present.

NCLEX: Stage 3: subcutaneous fat visible but no bone/tendon/muscle. Stage 4: bone/tendon/muscle exposed. This distinction is high-yield for NCLEX.

Stage 4

Full Thickness Tissue Loss

Skin Findings

Full thickness tissue loss with exposed or directly palpable bone, tendon, or muscle; slough or eschar may be present on portions; undermining and tunneling common

Tissue Involvement

All tissue layers destroyed — epidermis, dermis, subcutaneous fat, fascia; bone, tendon, or muscle directly exposed or palpable

Nursing Considerations

Monitor for osteomyelitis (probe-to-bone test positive = presumed osteomyelitis). Multidisciplinary team required. Assess for systemic infection. Negative pressure wound therapy (NPWT) may be ordered. Surgical consult may be necessary.

NCLEX: Stage 4 carries significant osteomyelitis risk. If a sterile probe contacts bone during wound assessment, osteomyelitis is presumed until proven otherwise.

Unstageable

Obscured Full Thickness

Skin Findings

Full thickness loss with wound bed obscured by slough (yellow, tan, gray, green) or eschar (tan, brown, black); true wound depth cannot be determined

Tissue Involvement

Full thickness — actual depth hidden; once debrided, typically reveals Stage 3 or 4 wound. Exception: stable dry adherent heel eschar is not debrided

Nursing Considerations

Document as unstageable. Assess for infection signs under eschar (odor, fluctuance, periwound changes). Debridement per provider order — do not debride without an order. Heel eschar exception: do not debride stable, dry, adherent heel eschar — it is a natural protective cover.

NCLEX: Unstageable ≠ unknown stage — it means the wound bed is obscured. Stable heel eschar is NOT debrided. This is a commonly tested NCLEX exception.

Deep Tissue PI

Persistent Deep Red / Purple Discoloration

Skin Findings

Non-blanchable deep red, maroon, or purple discoloration of intact or nearly intact skin; OR blood-filled blister; pain and temperature changes often precede visible changes

Tissue Involvement

Damage at the bone-muscle interface from intense and/or prolonged pressure and shear; overlying skin may appear intact while deeper tissue is already necrotic

Nursing Considerations

Immediate pressure relief. Monitor closely at every shift — may evolve rapidly to Stage 3 or 4 within hours or days despite optimal care. Notify provider. Document evolution carefully. Do not massage area over bony prominences.

NCLEX: DTI can evolve rapidly — it is not safe or stable. Intense pressure over bony prominence is the mechanism. Dark discoloration with intact skin = DTI until proven otherwise.

Quick Reference Summary

StageSkin Intact?Deepest Tissue VisibleKey Feature
Stage 1YesEpidermis (intact)Non-blanchable erythema
Stage 2No (open wound or blister)Dermis (partial)Shallow ulcer or blister; no slough
Stage 3NoSubcutaneous fatFull thickness; fat visible; no bone/tendon
Stage 4NoBone, tendon, or muscleBone/tendon/muscle exposed; osteomyelitis risk
UnstageableNoCannot determine (obscured)Slough/eschar obscures wound bed
Deep Tissue PIYes (or nearly)Deep tissue (not visible externally)Purple/maroon discoloration; may evolve rapidly

Related Resources

Standards & sources

Fact-checked Jun 21, 2026

This page is written to align with American Nurses Association (ANA) Standards of Practice · The Joint Commission. It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →